CN Patent

CN105998046A — 用于治疗造血性癌症和增殖性病症的固定药物比例

Assigned to Jazz Pharmaceuticals Therapeutics Inc · Expires 2016-10-12 · 10y expired

What this patent protects

本发明涉及用于治疗造血性癌症和增殖性病症的固定药物比例。本文中提供了通过给予药物组合物治疗癌症的方法，所述药物组合物包括固定的、非拮抗性摩尔比例的阿糖胞苷和蒽环类。这种方法对于治疗患有晚期血液学癌症或增殖性病症的患者特别有用。

USPTO Abstract

本发明涉及用于治疗造血性癌症和增殖性病症的固定药物比例。本文中提供了通过给予药物组合物治疗癌症的方法，所述药物组合物包括固定的、非拮抗性摩尔比例的阿糖胞苷和蒽环类。这种方法对于治疗患有晚期血液学癌症或增殖性病症的患者特别有用。

Drugs covered by this patent

Patent Metadata

Patent number
CN105998046A
Jurisdiction
CN
Classification
—
Expires
2016-10-12
Drug substance claim
No
Drug product claim
No
Assignee
Jazz Pharmaceuticals Therapeutics Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.